David Lamond, Director at Quince Therapeutics, holds 6.69M shares in Quince Therapeutics (Ticker: QNCX), holds 1.08M shares in Applied Molecular Transport (Ticker: AMTI), holds ― shares in Lucira Health (Ticker: LHDXQ). Most recently, David Lamond Bought ― shares of Quince Therapeutics on Dec 14, 2023 for an estimated value of 69.23K.
What is the percentage of profitable transactions made by David Lamond?
The percentage of profitable transactions made by David Lamond is 36%.
What is the average return per transaction made by David Lamond?
The average return per transaction made by David Lamond is -24.00%.
What stocks does David Lamond hold?
David Lamond holds: QNCX, AMTI, LHDXQ stocks.
What was David Lamond’s latest transaction?
David Lamond latest transaction was an Informative Buy of $69.23K.
What was David Lamond's most profitable transaction?
David Lamond’s most profitable transaction was an Informative Buy of QNCX stock on December 1, 2023. The return on the trade was 77.00%.
What is David Lamond's role in Quince Therapeutics?
David Lamond's role in Quince Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.